Jens‐Ulrich Stegmann

Author

GlaxoSmithKline (Belgium)ORCID

Also Known As

J ‐U Stegmann, J. Stegmann, J. U. Stegmann, J.-U Stegmann, J.-U. Stegmann, Jens-Ulrich Stegmann, Jens‐Ulrich Stegmann

Publications

940

Citations

H-Index

Concepts

All Affiliations

GlaxoSmithKline (Belgium)Christian-Albrechts-Universität zu Kiel Grünenthal Group (Germany)Johnson & Johnson (United States)Lagos State Health Service Commission

About

Jens‐Ulrich Stegmann is an author at GlaxoSmithKline (Belgium) specializing in medicine, physiology, and sympathetic nervous system.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	289
2	Engineering	1	1	28
3	Health Sciences	1	1	29
4	Applied Physiology	1	1	29
5	Health Informatics	1	1	28

Jens‐Ulrich Stegmann

Publications

860

Citations

H-Index

Page 1

	Year	Citations
Efficacy and tolerability of tapentadol immediate release and oxycodone HCl immediate release in patients awaiting primary joint replacement surgery for end-stage joint disease: A 10-day, phase III, randomized, double-blind, active- and placebo-controlled study Craig T. Hartrick, Ilse Van Hove, Jens‐Ulrich Stegmann, Clinical Therapeutics Phase IiiOsteoarthritisOrthopaedicsPlacebo-controlled StudyTapentadol Immediate Release	2009	179
A randomized, double-blind, placebo-controlled phase 3 study of the relative efficacy and tolerability of tapentadol IR and oxycodone IR for acute pain Stephen Daniels, Ed Casson, Jens‐Ulrich Stegmann, Current Medical Research and Opinion	2009	131
RSV Prefusion F Protein–Based Maternal Vaccine — Preterm Birth and Other Outcomes Ilse Dieussaert, Joon Hyung Kim, Sabine Luik, New England Journal of Medicine	2024	115
The efficacy and tolerability of multiple-dose tapentadol immediate release for the relief of acute pain following orthopedic (bunionectomy) surgery Jens‐Ulrich Stegmann, Horst Weber, Achim Steup, Current Medical Research and Opinion	2008	94
Safety profile of the RTS,S/AS01 malaria vaccine in infants and children: additional data from a phase III randomized controlled trial in sub-Saharan Africa Yolanda Guerra Mendoza, Elodie Garric, Amanda Leach, Human Vaccines & Immunotherapeutics	2019	65
Review of the initial post-marketing safety surveillance for the recombinant zoster vaccine Fernanda Tavares Da Silva, Maribel Miranda Co, Christophe Dessart, Vaccine	2019	39
Functional evidence for the differential control of superficial and deep blood vessels by sympathetic vasoconstrictor and primary afferent vasodilator fibres in rat hairless skin Heinz‐Joachim Häbler, Jens‐Ulrich Stegmann, Lars Timmermann, Experimental Brain Research NeurophysiologySympathetic Nervous SystemPhysiologyDifferential ControlVascular Biology	1998	30
Frequency response characteristics of sympathetic transmission to skin vascular smooth muscles in rats Harald M. Stauss, Jens‐Ulrich Stegmann, Pontus B. Persson, American Journal of Physiology-Regulatory, Integrative and Comparative Physiology Peripheral Nervous SystemBlood FlowFrequency BandPhysiological ResearchKinesiology	1999	29
Artificial intelligence and pharmacovigilance: What is happening, what could happen and what should happen? Andrew Bate, Jens‐Ulrich Stegmann Health Policy and Technology Artificial IntelligenceEngineeringResponsible AiMedicineAutomation	2023	28
Enhancing Pharmacovigilance in Sub-Saharan Africa Through Training and Mentoring: A GSK Pilot Initiative in Malawi Viviane Jusot, Frider Chimimba, Nettie Dzabala, Drug Safety	2020	24

Page 1